semaglutide tinnitus side effect PDF) The Risk of Vestibular Disorders with and Tirzepatide: Findings from a Large Real-World Cohort You might've heard of this

Our patients show our approach can lead to 15-20% body weight reduction, with potential for greater results over time

A team of researchers from the University of Iowa has unveiled concerns about the use of semaglutide, a widely prescribed GLP-1 receptor agonist for type 2 diabetes and obesity, in patients with neuroendocrine neoplasms (NENs)

Recent mega trials and meta-analyses provide standards for their use in obesity and type 2 diabetes management

It selectively binds to cardiolipin in the inner mitochondrial membrane, stabilizing the electron transport chain and reducing mitochondrial reactive oxygen species (ROS) production

High-sensitivity cardiac troponin I levels and prediction of heart failure: results from the BiomarCaRE consortium